Essra Ridha
Chief Tech/Sci/R&D Officer chez AVROBIO, INC.
Fortune : 20 328 $ au 31/03/2024
Profil
Essra Ridha is a Member at The Royal College of Physicians.
She is also currently serving as the Chief Medical Officer at Avrobio, Inc. In her former positions, she worked as a Senior Director-Medical at Sangamo Therapeutics, Inc. and as a Vice President-Clinical Development at Avrobio, Inc. Dr. Ridha completed her undergraduate studies at University College London and holds doctorate degrees from UCL Medical School and Royal Free Hospital Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVROBIO INC
0,04% | 05/02/2024 | 15 881 ( 0,04% ) | 20 328 $ | 31/03/2024 |
Postes actifs de Essra Ridha
| Sociétés | Poste | Début |
|---|---|---|
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01/10/2021 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Anciens postes connus de Essra Ridha
| Sociétés | Poste | Fin |
|---|---|---|
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01/07/2021 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Formation de Essra Ridha
| University College London | Undergraduate Degree |
| UCL Medical School | Doctorate Degree |
| Royal Free Hospital Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
